Evidence-based diuretics: focus on chlorthalidone and indapamide

Future Cardiology
James J DiNicolantonioJames H O'Keefe

Abstract

Thiazide and thiazide-like diuretics are cornerstone treatments for hypertension. However, unlike chlorthalidone (CTD) and indapamide (IDP), hydrochlorothiazide (HCTZ) lacks evidence for reducing morbidity and mortality as monotherapy compared with placebo or control. Despite this fact, HCTZ is prescribed much more frequently than CTD or IDP. We believe that all hypertension guidelines should follow the National Institute for Health and Excellence (NICE) and make IDP and CTD first choice 'thiazide-like diuretics.' This article will focus on the available evidence pertaining to HCTZ versus CTD and IDP. We will review the pharmacological differences between these three diuretics, as well as the clinical trial data and important side effects.

References

Sep 1, 1987·The American Journal of Cardiology·J D CohenK A Daniels
Jan 1, 1986·Drugs·P Leren, A Helgeland
Jul 1, 1984·Journal of Cardiovascular Pharmacology·J H KreeftR I Ogilvie
Jan 1, 1983·Current Medical Research and Opinion·G E Plante, C Robillard
Nov 1, 1995·The Annals of Pharmacotherapy·T Y Chan
Feb 22, 1996·The American Journal of Cardiology·P A CareyD Guez
Apr 1, 1997·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A W HoesJ Lubsen
Jan 5, 2000·Physiological Reviews·R F Reilly, D H Ellison
May 23, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A K Mantel-TeeuwisseA de Boer
Jan 5, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·P Weidmann
May 10, 2002·The Medical Journal of Australia·Michael D ChapmanJohn E Marley
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Feb 14, 2003·The New England Journal of Medicine·Lindon M H WingUNKNOWN Second Australian National Blood Pressure Study Group
Mar 26, 2003·Hypertension·Carl Erik MogensenUNKNOWN Preterax in Albuminuria Regression (PREMIER) Study Group
Feb 1, 1959·The American Journal of Cardiology·M MOSER, A I MACAULAY
Mar 1, 1959·The Ohio State Medical Journal·J MESSINA
Jul 1, 1952·Circulation·J N CAPPSR F PITTS
Dec 15, 2004·Archives of Internal Medicine·Peter W de LeeuwGilbert Wagener
Dec 28, 2004·The American Journal of Cardiology·John B KostisUNKNOWN SHEP Collaborative Research Group
Feb 24, 2005·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Jean-Philippe BaguetPascal Auquier
Apr 2, 2005·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Alun D Hughes
Feb 8, 2006·American Journal of Hypertension·Gerard LondonRolland Asmar

❮ Previous
Next ❯

Citations

Dec 26, 2018·Hypertension·Robert M CareyPaul Muntner
Feb 6, 2018·Current Diabetes Reports·André J Scheen
Oct 26, 2018·Hypertension·Robert M CareyUNKNOWN American Heart Association Professional/Public Education and Publications Committee of the Council on Hypertension; Council

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.